^
BIOMARKER:

KMT2A rearrangement

i
Other names: KMT2A, Lysine Methyltransferase 2A, Histone-Lysine N-Methyltransferase 2A, CXXC7, TRX1, Myeloid/Lymphoid Or Mixed-Lineage Leukemia (Trithorax Homolog, Drosophila), Lysine (K)-Specific Methyltransferase 2A, CXXC-Type Zinc Finger Protein 7, Lysine N-Methyltransferase 2A, Zinc Finger Protein HRX, Trithorax-Like Protein, HTRX1, MLL1A, MLL1, MLL, Myeloid/Lymphoid Or Mixed-Lineage Leukemia (Trithorax (Drosophila) Homolog), Myeloid/Lymphoid Or Mixed-Lineage Leukemia Protein 1, Myeloid/Lymphoid Or Mixed
Entrez ID:
Related biomarkers:
KMT2A rearrangement
ALL
CEP-701
Sensitive: B - Late Trials
KMT2A rearrangement
AML
gemtuzumab ozogamicin
Sensitive: C3 – Early Trials
KMT2A rearrangement
ALL
azacitidine
Sensitive: C4 – Case Studies
KMT2A rearrangement
Childhood B Acute Lymphoblastic Leukemia
DS-M1
Sensitive: D – Preclinical